Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
002675.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | CN¥2,868,937 | CN¥3,275,648 | CN¥3,582,955 | CN¥3,912,050 |
| % Growth | -12.4% | -8.6% | -8.4% | – |
| Cost of Goods Sold | CN¥1,521,289 | CN¥1,921,564 | CN¥2,050,683 | CN¥2,324,292 |
| Gross Profit | CN¥1,347,648 | CN¥1,354,084 | CN¥1,532,273 | CN¥1,587,758 |
| % Margin | 47% | 41.3% | 42.8% | 40.6% |
| R&D Expenses | CN¥298,933 | CN¥197,223 | CN¥163,520 | CN¥137,558 |
| G&A Expenses | CN¥303,441 | CN¥239,315 | CN¥210,802 | CN¥202,604 |
| SG&A Expenses | CN¥718,704 | CN¥747,888 | CN¥777,751 | CN¥795,180 |
| Sales & Mktg Exp. | CN¥415,263 | CN¥508,573 | CN¥566,949 | CN¥592,576 |
| Other Operating Expenses | CN¥109,205 | CN¥67,310 | CN¥142,750 | CN¥298,088 |
| Operating Expenses | CN¥1,126,842 | CN¥1,012,422 | CN¥1,084,021 | CN¥1,230,826 |
| Operating Income | CN¥220,806 | CN¥341,662 | CN¥448,252 | CN¥356,932 |
| % Margin | 7.7% | 10.4% | 12.5% | 9.1% |
| Other Income/Exp. Net | -CN¥1,703 | -CN¥4,381 | -CN¥2,675 | -CN¥833 |
| Pre-Tax Income | CN¥219,103 | CN¥337,282 | CN¥445,576 | CN¥356,099 |
| Tax Expense | CN¥77,678 | CN¥83,065 | CN¥92,749 | CN¥95,249 |
| Net Income | CN¥183,826 | CN¥209,736 | CN¥307,291 | CN¥151,561 |
| % Margin | 6.4% | 6.4% | 8.6% | 3.9% |
| EPS | 0.223 | 0.254 | 0.38 | 0.189 |
| % Growth | -12.4% | -33.1% | 101.2% | – |
| EPS Diluted | 0.223 | 0.254 | 0.38 | 0.189 |
| Weighted Avg Shares Out | 824,596 | 824,757 | 807,806 | 802,214 |
| Weighted Avg Shares Out Dil | 824,596 | 824,757 | 807,806 | 802,214 |
| Supplemental Information | – | – | – | – |
| Interest Income | CN¥5,557 | CN¥12,780 | CN¥13,197 | CN¥5,121 |
| Interest Expense | CN¥98,235 | CN¥59,319 | CN¥61,994 | CN¥59,030 |
| Depreciation & Amortization | CN¥150,081 | CN¥137,920 | CN¥120,373 | CN¥114,931 |
| EBITDA | CN¥432,688 | CN¥511,691 | CN¥672,089 | CN¥727,923 |
| % Margin | 15.1% | 15.6% | 18.8% | 18.6% |